Candidiasis Market to Witness High Growth Driven by Increasing Prevalence and Antifungal Drug Development
A) Market Overview:The global Candidiasis Market is estimated to be valued at US$873.8 million in 2017 and is expected to reach US$XX million by 2022, growing at a CAGR of 4.6% during the forecast period. Candidiasis is a fungal infection caused by Candida species, mainly Candida albicans. It can affect various parts of the body, such as the skin, mouth, throat, genitals, and bloodstream. The...
0 Comments 0 Shares 1417 Views 0 Reviews
Sponsored